Immune checkpoint inhibitors: immune-related adverse events, healthcare utilization, and costs among commercial and Medicare Advantage patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1433-7339
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Immune checkpoint inhibitors: immune-related adverse events, healthcare utilization, and costs among commercial and Medicare Advantage patients ; volume:30 ; number:5 ; day:21 ; month:1 ; year:2022 ; pages:4019-4026 ; date:5.2022
Supportive care in cancer ; 30, Heft 5 (21.1.2022), 4019-4026, 5.2022
- Creator
-
Gunturu, Krishna S.
Pham, Timothy T.
Shambhu, Sonali
Fisch, Michael J.
Barron, John J.
Debono, David
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00520-022-06826-9
- URN
-
urn:nbn:de:101:1-2022061419382430640204
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gunturu, Krishna S.
- Pham, Timothy T.
- Shambhu, Sonali
- Fisch, Michael J.
- Barron, John J.
- Debono, David
- SpringerLink (Online service)
Other Objects (12)
Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors
Mechanisms of Immune-Related Complications in Cancer Patients Treated with Immune Checkpoint Inhibitors
Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?
Steroid-Refractory Immune-Related Adverse Events Induced by Checkpoint Inhibitors
Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series
Immune-related serious adverse events with immune checkpoint inhibitors: Systematic review and network meta-analysis
Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors
Immune-related aseptic meningitis and strategies to manage immune checkpoint inhibitor therapy: a systematic review
Severe neuromuscular immune-related adverse events of immune checkpoint inhibitors at national cancer center in Korea
Significant association between tumor mutational burden and immune-related adverse events during immune checkpoint inhibition therapies
Intrahepatic Bile Duct Injury as a Hepatic Immune-Related Adverse Event after Immune-Checkpoint Inhibitor Treatment
Concurrent therapy with immune checkpoint inhibitors and TNFα blockade in patients with gastrointestinal immune-related adverse events
Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors
Mechanisms of Immune-Related Complications in Cancer Patients Treated with Immune Checkpoint Inhibitors
Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?
Steroid-Refractory Immune-Related Adverse Events Induced by Checkpoint Inhibitors
Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series
Immune-related serious adverse events with immune checkpoint inhibitors: Systematic review and network meta-analysis
Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors
Immune-related aseptic meningitis and strategies to manage immune checkpoint inhibitor therapy: a systematic review
Severe neuromuscular immune-related adverse events of immune checkpoint inhibitors at national cancer center in Korea
Significant association between tumor mutational burden and immune-related adverse events during immune checkpoint inhibition therapies
Intrahepatic Bile Duct Injury as a Hepatic Immune-Related Adverse Event after Immune-Checkpoint Inhibitor Treatment
Concurrent therapy with immune checkpoint inhibitors and TNFα blockade in patients with gastrointestinal immune-related adverse events
Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors
Mechanisms of Immune-Related Complications in Cancer Patients Treated with Immune Checkpoint Inhibitors
Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?
Steroid-Refractory Immune-Related Adverse Events Induced by Checkpoint Inhibitors
Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series
Immune-related serious adverse events with immune checkpoint inhibitors: Systematic review and network meta-analysis
Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors
Immune-related aseptic meningitis and strategies to manage immune checkpoint inhibitor therapy: a systematic review
Severe neuromuscular immune-related adverse events of immune checkpoint inhibitors at national cancer center in Korea
Significant association between tumor mutational burden and immune-related adverse events during immune checkpoint inhibition therapies
Intrahepatic Bile Duct Injury as a Hepatic Immune-Related Adverse Event after Immune-Checkpoint Inhibitor Treatment